Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Granulocytes from the peripheral blood of patients with
chronic myeloid leukemia
(
CML
) exhibit a number of functional defects. To explore the relationship of these aberrations to signal transduction, granulocytes from normal subjects and
CML
patients were labelled with 32Pi, stimulated with phorbol myristate acetate (PMA) and the phosphoproteins (Pps) in the unstimulated and stimulated cells analyzed by 2D-SDS-PAGE followed by autoradiography. Results show that there are six distinct reproducibly phosphorylated proteins referred to as Pp1-Pp6 identifiable in the basal patterns of the resting granulocytes. Amongst these, Pp1 and Pp5 are more intensely phosphorylated and Pp3 is very faint or absent in unstimulated
CML
cells, relative to the normal granulocytes. On stimulation of normal cells with PMA, Pp1, Pp3,
Pp4
and Pp6 exhibit distinct patterns of phosphorylation-dephosphorylation. In the
CML
cells, however, Pp1 and
Pp4
are unresponsive to PMA. We conclude that PKC-mediated functions involving Pp1, Pp3 and
Pp4
are most probably defective in
CML
cells.
...
PMID:Differential phosphorylation in normal and leukemic granulocytes in response to phorbol 12-myristate 13-acetate. 818 23